✦ LIBER ✦

Tumor escape mechanisms: potential role of soluble HLA antigens and NK cells activating ligands

✍ Scribed by M. Campoli; S. Ferrone

Book ID: 110892833
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 614 KB
Volume: 72
Category: Article
ISSN: 0001-2815
DOI: 10.1111/j.1399-0039.2008.01106.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

HLA antigen and NK cell activating ligan

HLA antigen and NK cell activating ligand expression in malignant cells: a story of loss or acquisition

✍ Michael Campoli; Soldano Ferrone 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 587 KB

Antigen Presentation Machinery (APM) Mod

Antigen Presentation Machinery (APM) Modulation and Soluble HLA Molecules in the Tumor Microenvironment: Do They Provide Tumor Cells with Escape Mechanisms from Recognition by Cytotoxic T Lymphocytes?

✍ Bangia, Naveen; Ferrone, Soldano 📂 Article 📅 2006 🏛 Informa plc 🌐 English ⚖ 203 KB

Soluble HLA-I-mediated secretion of TGF-

Soluble HLA-I-mediated secretion of TGF-β1 by human NK cells and consequent down-regulation of anti-tumor cytolytic activity

✍ Massimo Ghio; Paola Contini; Simone Negrini; Silvia Boero; Alessandra Musso; Ale 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 374 KB

SUBVERSIVE ACTIVITY OF SYNGENEIC TUMOR C

SUBVERSIVE ACTIVITY OF SYNGENEIC TUMOR CELLS AS AN ESCAPE MECHANISM FROM IMMUNE SURVEILLANCE AND THE ROLE OF PROSTAGLANDINS

✍ Otto J. Plescia; Kazimiera Grinwich; Anne M. Plescia 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 444 KB

Expression of HLA class I, β2-microglobu

Expression of HLA class I, β2-microglobulin, TAP1 and IL-10 in Epstein-Barr virus-associated nasal NK/T-cell lymphoma: Implications for tumor immune escape mechanism

✍ Lijun Shen; Alan K.S. Chiang; Wei Ping Liu; Gan Di Li; Raymond H.S. Liang; Gopes 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 536 KB

Several mechanisms of immune escape might be in operation in Epstein-Barr virus (EBV)-associated nasal NK/T-cell lymphoma. We have previously shown the downregulation of the immunogenic EBV nuclear antigens by alternative promoter usage and the preferential selection of the deletion genotype of late